Status:
UNKNOWN
Risk Profile for Patients With Atrial Fibrillation
Lead Sponsor:
I.C. Van Gelder
Collaborating Sponsors:
Netherlands Heart Foundation
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to assess the risk profile in patients with atrial fibrillation, which represents the degree of changes in the atrial tissue and which can help predict in which patients...
Detailed Description
Atrial fibrillation is responsible for substantial morbidity and mortality.Identification of patients with atrial fibrillation that is difficult to treat may improve the outcome of rhythm control ther...
Eligibility Criteria
Inclusion
- Short-lasting symptomatic paroxysmal or persistent AF;
- Rhythm control strategy is preferred;
- No contra-indication for oral anticoagulation;
- Age \> 18 years;
- Written informed consent
Exclusion
- Total history of heart failure and/ or of severe valvular disease \> 3 years;
- Severe valvular disease;
- Acute coronary syndrome/ myocardial infarction/ percutaneous coronary intervention/ coronary artery bypass surgery within the past one month;
- Post-operative AF.
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01510210
Start Date
April 1 2011
End Date
March 1 2025
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9713 GZ Groningen